Annual Decline in Pentraxin 3 Is a Risk of Vascular Access Troubles in Hemodialysis Patients

Table 2

Comparison of pentraxin levels in baseline year among the subpopulations.

	Mean	SD	Mean	SD	value
Sex	Male ( = 45)		Female ( = 31)
Pentraxin 3	4.627	2.722	4.466	1.27	0.731
hsCRP	0.658	0.126	0.685	0.182	0.474
DM	Non-DM ( = 45)		DM ( = 31)
Pentraxin 3	4.946	2.422	4.005	1.83	0.058
hsCRP	0.675	0.18	0.661	0.096	0.656
Age	<65 years ( = 31)		≥65 years ( = 45)
Pentraxin 3	4.447	1.898	4.64	2.459	0.701
hsCRP	0.661	0.15	0.674	0.153	0.71
Dialysis-period	<5 years ( = 34)		≥5 years ( = 42)
Pentraxin 3	3.961	1.852	5.048	2.416	0.03
hsCRP	0.66	0.127	0.676	0.168	0.641
Body mass index	≥22 kg/m^2 ( = 32)		<22 kg/m^2 ( = 44)
Pentraxin 3	5.175	2.397	3.719	1.689	0.00
hsCRP	0.649	0.178	0.683	0.127	0.36

Data at baseline year was presented. Values of pentraxin 3 or hsCRP are expressed by ng/mL or mg/dL. DM: diabetes mellitus; hsCRP: high-sensitivity C-reactive protein. < 0.05, < 0.01.